Cognition Therapeutics Stock Soars After FDA Meeting: What’s Driving the Hype?
Alright, folks, let’s talk about a stock that’s lighting up the market today like a Fourth of July firework: Cognition Therapeutics (NASDAQ: CGTX). As of this writing, CGTX is rocketing, with shares spiking over 70% in early trading. Why the big move? The company...